The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Glutathione Depletion in PC12 Results in Selective Inhibition of Mitochondrial Complex I Activity
Open accessAbstract
Oxidative stress appears to play an important role in degeneration of dopaminergic neurons of the substantia nigra (SN) associated with Parkinson's disease (PD). The SN of early PD patients have dramatically decreased levels of the thiol tripeptide glutathione (GSH). GSH plays multiple roles in the nervous system both as an antioxidant and a redox modulator. We have generated dopaminergic PC12 cell lines in which levels of GSH can be inducibly down-regulated via doxycycline induction of antisense messages against both the heavy and light subunits of gamma-glutamyl-cysteine synthetase, the rate-limiting enzyme in glutathione synthesis. Down-regulation of glutamyl-cysteine synthetase results in reduction in mitochondrial GSH levels, increased oxidative stress, and decreased mitochondrial function. Interestingly, decreases in mitochondrial activities in GSH-depleted PC12 cells appears to be because of a selective inhibition of complex I activity as a result of thiol oxidation. These results suggest that the early observed GSH losses in the SN may be directly responsible for the noted decreases in complex I activity and the subsequent mitochondrial dysfunction, which ultimately leads to dopaminergic cell death associated with PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Griffith, O. W. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90139-6 · Cited by 4,602
Glutathione metabolism and its selective modification.
Meister, A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77815-6 · Cited by 2,011
Berridge, M. V., & Tan, A. S. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1311 · Cited by 1,435
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoy‐Agid, F., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360305 · Cited by 1,161
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981
[37] Reaction of protein sulfhydryl groups with Ellman's reagent
Habeeb, A. F. S. A. (1972) · Methods in Enzymology · doi:10.1016/s0076-6879(72)25041-8 · Cited by 901
ROLE OF REVERSIBLE OXIDATION-REDUCTION OF ENZYME THIOLS-DISULFIDES IN METABOLIC REGULATION
Ziegler, D. M. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.001513 · Cited by 836
Parkinson's disease: A disorder due to nigral glutathione deficiency?
Perry, T. L., Godin, D. V., & Hansen, S. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90390-1 · Cited by 753
Trounce, I. A., Kim, Y. L., Jun, A. S., & Wallace, D. C. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)64044-0 · Cited by 746
The oxidative inactivation of mitochondrial electron transport chain components and ATPase.
Zhang, Y., Marcillat, O., Giulivi, C., Ernster, L., & Davies, K. J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46227-2 · Cited by 716
Haas, R. H., Nasirian, F., Nakano, K., Ward, D., Pay, M., Hill, R., & Shults, C. W. (1995) · Annals of Neurology · doi:10.1002/ana.410370604 · Cited by 435
Glutathione deficiency leads to mitochondrial damage in brain.
Jain, A., Mårtensson, J., Stole, E., Auld, P. A., & Meister, A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1913 · Cited by 428
Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study
Dexter, D. T., Holley, A. E., Flitter, W. D., Slater, T. F., Wells, F. R., Daniel, S. E., Lees, A. J., Jenner, P., & Marsden, C. D. (1994) · Movement Disorders · doi:10.1002/mds.870090115 · Cited by 407
Huang, C. S., Chang, L. S., Anderson, M. E., & Meister, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36569-x · Cited by 374
Perry, T. L., & Yong, V. W. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90320-4 · Cited by 361
Energy Thresholds in Brain Mitochondria
Davey, G. P., Peuchen, S., & Clark, J. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12753 · Cited by 361
Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease
Pearce, R. K. B., Owen, A., Daniel, S., Jenner, P., & Marsden, C. D. (1997) · Journal of Neural Transmission · doi:10.1007/bf01291884 · Cited by 350
Glutathione‐related enzymes in brain in Parkinson's disease
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360306 · Cited by 296
Parkinson disease: A new link between monoamine oxidase and mitochondrial electron flow
Cohen, G., Farooqui, R., & Kesler, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.4890 · Cited by 286
Hallman, H., Lange, L., Olson, L., Strömberg, I., & Jonsson, G. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07120.x · Cited by 281
[47] Glutathione biosynthesis; γ-glutamylcysteine synthetase from rat kidney
Seelig, G. F., & Meister, A. (1985) · Methods in Enzymology · doi:10.1016/s0076-6879(85)13050-8 · Cited by 265
Mattson, M. P., Zhang, Y., & Bose, S. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1066 · Cited by 264
Ku, H.-H., & Sohal, R. S. (1993) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(93)90132-b · Cited by 240
Jung, C.-H., & Thomas, J. A. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0482 · Cited by 185
Reduced intravenous glutathione in the treatment of early parkinson's disease
Sechi, G., Deledda, M. G., Bua, G., Satta, W. M., Deiana, G. A., Pes, G. M., & Rosati, G. (1996) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(96)00103-0 · Cited by 173
Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease
Jenner, P. (1993) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb00013.x · Cited by 163
Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones
Wüllner, U., Löschmann, P. A., Schulz, J. B., Schmid, A., Dringen, R., Eblen, F., Turski, L., & Klockgether, T. (1996) · Neuroreport · doi:10.1097/00001756-199603220-00018 · Cited by 152
Mitochondrial complex I defects in aging.
Lenaz, G., Bovina, C., Castelluccio, C., Fato, R., Formiggini, G., Genova, M. L., Marchetti, M., Pich, M. M., Pallotti, F., Castelli, G. P., et al. (1997) · PubMed · Cited by 149
Mitochondrial Complex I defects in aging
Lenaz, G., Bovina, C., Castelluccio, C., Fato, R., Formiggini, G., Genova, M. L., Marchetti, M., Pich, M. M., Pallotti, F., Castelli, G. P., et al. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006854619336 · Cited by 140
Ravindranath, V., & Reed, D. J. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92004-j · Cited by 134
Glutathione and protein thiol homeostasis in brain during reperfusion after cerebral ischemia.
Shivakumar, B. R., Kolluri, S., & Ravindranath, V. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10589-2 · Cited by 119
Inhibition of mitochondrial complex I by haloperidol: the role of thiol oxidation
Balijepalli, S. Y. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00215-9 · Cited by 97
Hung, H.-C., & Lee, E. H. Y. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00206-2 · Cited by 95
Sriram, K., Shankar, S. K., Boyd, M. R., & Ravindranath, V. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-24-10287.1998 · Cited by 88
Thiol dependent oxidation of enzymes: The last chance against oxidative stress
CORSO, A. D., Cappiello, M., & Mura, U. (1994) · International Journal of Biochemistry · doi:10.1016/0020-711x(94)90103-1 · Cited by 85
Andersen, J. K., Mo, J. Q., Hom, D. G., Lee, F. Y., Harnish, P. P., Hamill, R. W., & McNeill, T. H. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67052164.x · Cited by 66
Self-citationEffects of arachidonic acid on respiratory activities in isolated brain mitochondria
Hillered, L., & Chan, P. H. (1988) · Journal of Neuroscience Research · doi:10.1002/jnr.490190113 · Cited by 57
Bannon, M. J., Goedert, M., & Williams, B. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90682-8 · Cited by 50
Cited by
Oxidative stress in neurodegeneration: Cause or consequence?
Andersen, J. K. (2004) · Nature Medicine · doi:10.1038/nrn1434 · Cited by 1,869
Self-citationMechanism of Toxicity in Rotenone Models of Parkinson's Disease
Sherer, T. B., Betarbet, R., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno-Yagi, A., & Greenamyre, J. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10756.2003 · Cited by 1,072
Self-citationHanschmann, E.-M., Godoy, J. R., Berndt, C., Hudemann, C., & Lillig, C. H. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4599 · Cited by 677
Animal models of Parkinson's disease
Betarbet, R., Sherer, T. B., & Greenamyre, J. T. (2002) · BioEssays · doi:10.1002/bies.10067 · Cited by 592
Self-citationLee, W.-H., Loo, C.-Y., Bebawy, M., Luk, F., Mason, R., & Rohanizadeh, R. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311040002 · Cited by 537
Metadata
- Authors
- Jha, N., Jurma, O., Lalli, G., Liu, Y., Pettus, E. H., Greenamyre, J. T., Liu, R.-M., Forman, H. J., & Andersen, J. K.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-08
- Volume
- 275
- Issue
- 34
- Pages
- 26096-26101
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2145391370
- Cited by
- 252
- References
- 39
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.